The U.S. plasmid DNA manufacturing market, valued at USD 821.98 million in 2024, is projected to grow at a compound annual growth rate (CAGR) of 23.3% from 2025 to 2034, driven by the explosive demand for plasmid DNA (pDNA) as a foundational component in gene therapies, mRNA vaccines, and viral vector production. As the biopharmaceutical industry shifts toward advanced modalities such as CAR-T,...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek